ICYMI: EMA Grants Orphan Drug Designation to CAN-2409 for Glioma
According to a September 2022 article from OncLive, the European Medicines Agency (EMA) granted Orphan Drug designation to CAN-2409. This therapy is being developed as a potential therapeutic option for…